##plugins.themes.academic_pro.article.main##
Abstract
Chronic heart failure (CHF) and obesity are widespread in the population and often coexist, increasing the risk of complications in this category of patients. In patients with heart failure (HF), the prevalence of obesity is 32-49%. At the same time, most of the patients are pre-represented by persons with HF and a preserved LV ejection fraction. Obesity is an independent risk factor for heart failure. It is shown that as the body mass index increases for every 1 kg/m2 , the risk of developing HF increases by 7% in women and 5% in men. Chronic heart failure (CHF) and obesity are widespread in the population and often coexist, increasing the risk of complications in this category of patients. In patients with heart failure (CHF), the prevalence of obesity is 32-49%. At the same time, most of the patients are represented by persons with HF and a preserved LV ejection fraction. Obesity is an independent risk factor for heart failure. It has been shown that as the body mass index (BMI) increases for every 1 kg/m2 , the risk of developing HF increases by 7% in women and by 5% in men. Obesity has become a worldwide epidemic, and its prevalence is projected to increase by 40% in the next decade. The growing prevalence of obesity has an impact on the risk of developing diabetes mellitus, cardiovascular diseases, as well as chronic kidney disease (CKD). A high body mass index is one of the most significant risk factors for CKD. In obese individuals, compensatory hyperfiltration develops in response to an increase in the metabolic needs of overweight. An increase in intraclubular pressure can lead to kidney damage and an increased risk of developing CKD in the long term. In recent years, the incidence of glomerulopathy associated with obesity has increased 10-fold. In addition, obesity has been shown to be a risk factor for nephrolithiasis and a number of malignant neoplasms, including kidney cancer.
Keywords
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
- Alisherovna, K. M., Davranovna, M. H., & Nizametdinovich, K. S. (2022). Chronic Heart Failure in Women. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 3(1), 21-25.
- Alisherovna, K. M., Toshtemirovna, E. M. M., & Oybekovna, E. E. (2022). QUALITY OF LIFE OF PATIENTS WITH CIRRHOSIS OF THE LIVER. Spectrum Journal of Innovation, Reforms and Development, 4, 197-202.
- Alisherovna, K. M., Toshtemirovna, E. M. M., Duskobilovich, B. S., & Umirxanovna, K. G. (2022). DYSFUNCTION LEFT VENTRICULAR IN BRONCHIAL ASTHMA. Spectrum Journal of Innovation, Reforms and Development, 4, 216-221.
- Buribayevich, N. M. (2022). Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 3(1), 183-186.
- Erkinovna, K. Z., Davranovna, M. K., Toshtemirovna, E. M. M., & Xudoyberdiyevich, G. X. (2022). CORRECTION OF COMPLICATIONS IN CHRONIC HEART FAILURE DEPENDING ON THE FUNCTIONAL STATE OF THE KIDNEYS. Web of Scientist: International Scientific Research Journal, 3(5), 565-575.
- Gaffarov, X. X. (2021). DISEASES OF THE THYROID GLAND. Scientific progress, 2(3), 938-940.
- Makhmudova, K. D., & Gaffarov, H. H. (2021, February). STUDYING THE LIVER FUNCTION IN BURN RECONVALESCENTS. In Archive of Conferences (Vol. 15, No. 1, pp. 208-210).
- Toshtemirovna, E. M. M., Nizamitdinovich, K. S., Tadjiyevich, X. A., & Xudoyberdiyevich, G. X. (2022). ASSESSMENT OF RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE.
- Totilboyevich, Y. S. (2021). CHARACTER OF IHD COURSE IN WOMEN OF CLIMACTERIC AGE. Web of Scientist: International Scientific Research Journal, 2(11), 175-178.
- Totlibayevich, Y. S. (2022). THE QUALITY OF LIFE OF PATIENTS WITH CIRRHOSIS OF THE LIVER DEPENDING ON THE TONE OF THE AUTONOMIC NERVOUS SYSTEM. Web of Scientist: International Scientific Research Journal, 3(5), 589-596.
- Xaydarov, S. N., & Normatov, M. B. (2021). DETERMINATION OF IRON DEFICIENCY ANEMIA AT THE PREGNANCY PERIOD. Scientific progress, 2(4), 325-327.
- Yarmukhamedova, S. (2020). ASSESSMENT OF SIGNS OF DIASTOLIC DYSFUNCTION OF THE RIGHT VENTRICLE IN PATIENTS WITH ARTERIAL HYPERTENSION. InterConf.
- Yarmukhamedova, S. (2020). SURUNKALI GLOMERULONEFRIT BILAN OG ‘RIGAN BEMORLARDA ARTERIAL QON BOSIMINING SUTKALIK MONITORING KO ‘RSATKICHLARINI BAXOLASH. Журнал кардиореспираторных исследований, 1(1), 103-108.
- Zikiryayevna, S. G., Muxtorovna, E. M., Jurakulovich, U. I., & To’raqulovna, Q. S. (2022). PAINLESS CARDIAC ISCHEMIA IN WOMEN WITH RHEUMATOID ARTHRITIS. Web of Scientist: International Scientific Research Journal, 3(10), 397-405.
- Zikriyaevna, S. G., & Muhtorovna, E. M. (2019). The features of the early diagnostics of osteoporosis in patients with rheumatoid arthritis. Достижения науки и образования, (12 (53)), 110-112.
- Zokhidovna, K. Z., & Xudoyberdiyevich, G. X. (2022). " ISOLATED" DIASTOLIC MYOCARDIAL DYSFUNCTION IN DIABETES MELLITUS. Spectrum Journal of Innovation, Reforms and Development, 7, 101-107.
- Норматов, М. Б. (2022). EFFICACY OF AMLODIPINE IN ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS. Журнал кардиореспираторных исследований, 3(1).
- Тоиров, Д. Р., & Махмудова, Х. Д. (2021). ПОДАГРА КАСАЛЛИГИ БИЛАН ОҒРИГАН БЕМОРЛАРДА ЮРАК ҚОН-ТОМИР ЗАРАРЛАНИШЛАРИ. Scientific progress, 2(2), 242-249.
- Хайдарова, З. (2021). ЭНТРОПИЯ И НАРУШЕНИЯ СЕРДЕЧНОГО РИТМА У БОЛЬНЫХ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА. Журнал кардиореспираторных исследований, 2(4), 59-62.
- Эргашова, М. М., & Шодикулова, Г. З. (2021). РЕВМАТОИД АРТРИТ ВА ИККИЛАМЧИ ОСТЕОАРТРОЗ КАСАЛЛИГИ БОР БЕМОРЛАРДА ЮРАК ГЕМОДИНАМИКАСИНИНГ ЎЗИГА ХОС ХУСУСИЯТЛАРИ. ЖУРНАЛ БИОМЕДИЦИНЫ И ПРАКТИКИ, 6(1).
- Ярмухаммедова, С. (2020). ОЦЕНКА ПРИЗНАКОВ ДИАСТОЛИЧЕСКОЙ ДИСФУНКЦИИ ПРАВОГО ЖЕЛУДОЧКА У БОЛЬНЫХ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ. Журнал кардиореспираторных исследований, 1(2), 88-92.